Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
4 Patents
#75 in Bothell, WA
#1,464 in Washington
#60,671 in US
Mdrna, Inc.
Forward Citations = 43
10 inventors:
Bothell, WA, United States of America
Mdrna, Inc.
Calculating rank
% Expired Patents = 100.0
EPO Patents = 1
Forward Citations = 43
Loading Chart...
Loading Chart...
10 inventors (with patents filed for the assignee):
Douglas L Badders (2 out of 4 patents)
Richard E Herman (2 out of 10 patents)
Mark Fuller (2 out of 3 patents)
4. Ekaterina G Makienko (2 out of 2 patents)
5. Henry R Costantino (1 out of 91 patents)
6. Benjamin H Dutzar (1 out of 72 patents)
7. Steven C Quay (1 out of 94 patents)
8. Kunyuan Cui (1 out of 6 patents)
9. Mary S Kleppe (1 out of 5 patents)
10. Ching-Yuan Li (1 out of 2 patents)
11. Annemarie Stoudt Cohen (1 patent)
12. Anthony P Sileno (18 patents)
13. Shu-Chih Chen Quay (0 patent)
4 patents:
Company Overview
Mdrna, Inc. is a biotechnology company focused on the development of novel RNA-based therapeutics. The company leverages its proprietary platform technology to design and develop innovative RNA-based drugs for the treatment of various diseases, including cancer and infectious diseases. Mdrna, Inc. is committed to advancing the field of RNA therapeutics through cutting-edge research and development efforts.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Mdrna, Inc.. Retrieved from https://idiyas.com/company/mdrna
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]